Psychometric properties of the Liebowitz Social Anxiety Scale

BACKGROUND The present study provides data on the reliability, validity and treatment sensitivity of the Liebowitz Social Anxiety Scale (LSAS), one of the most commonly used clinician-administered scales for the assessment of social phobia. METHOD Three hundred and eighty-two patients from several studies of the treatment of social phobia were evaluated. An independent assessor administered the LSAS to each patient prior to the initiation of treatment. Patients also completed other measures of social anxiety and avoidance, although the specific measures varied across samples. RESULTS The LSAS and its subscales were normally distributed and demonstrated excellent internal consistency. The convergent validity of the LSAS was demonstrated via significant correlations with other commonly-used measures of social anxiety and avoidance. These correlations also tended to be larger than correlations with measures of depression, especially after treatment. However, the pattern of correlations of LSAS subscales with one another and with the other measures suggest that the fear subscales and the avoidance subscales may not be sufficiently distinct in clinical samples. The LSAS was also demonstrated to be sensitive to the effects of pharmacological treatments of social phobia over time and in comparison to double-blind pill placebo. CONCLUSION The LSAS appears to be a reliable, valid and treatment sensitive measure of social phobia. Further study of the LSAS, both in samples with severe social phobia and in community samples, is needed.

[1]  W. F. Murphy,et al.  The clinical interview , 1955 .

[2]  M. Liebowitz,et al.  Functional impairment in social phobia. , 1994, The Journal of clinical psychiatry.

[3]  M. Liebowitz,et al.  The issue of subtypes in the diagnosis of social phobia , 1993 .

[4]  J. Herbert An overview of the current status of social phobia , 1995 .

[5]  R. Rapee Descriptive psychopathology of social phobia. , 1995 .

[6]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[7]  Ralph L. Rosnow,et al.  Essentials of Behavioral Research: Methods and Data Analysis , 1984 .

[8]  D. Klein,et al.  Schedule for Affective Disorders and Schizophrenia--Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development. , 1986, Journal of psychiatric research.

[9]  R. Swinson,et al.  Suicidal ideation and suicide attempts in panic disorder and social phobia. , 1994, The American journal of psychiatry.

[10]  K. Krishnan,et al.  The Brief Social Phobia Scale. , 1991, The Journal of clinical psychiatry.

[11]  L. Hedges,et al.  Statistical Methods for Meta-Analysis , 1987 .

[12]  C M Miner,et al.  The Brief Social Phobia Scale: a psychometric evaluation , 1997, Psychological Medicine.

[13]  R. Heimberg,et al.  Social phobia subtype and avoidant personality disorder: Effect on severity of social phobia, impairment, and outcome of cognitive behavioral treatment , 1995 .

[14]  K. Kobak,et al.  Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study. , 1997, Journal of clinical psychopharmacology.

[15]  R. Kessler,et al.  Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. , 1996, Archives of general psychiatry.

[16]  R. Heimberg,et al.  Self selection and sample selection in a treatment study of social phobia. , 1995, Behaviour research and therapy.

[17]  Dan J Stein Social Phobia: Clinical and Research Perspectives , 1999, CNS Spectrums.

[18]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[19]  J. Davidson,et al.  Treatment of social phobia with clonazepam and placebo. , 1993, Journal of clinical psychopharmacology.

[20]  R. Heimberg,et al.  Homework compliance, perceptions of control, and outcome of cognitive-behavioral treatment of social phobia. , 1996, Behaviour research and therapy.

[21]  J. Reich,et al.  A pilot study of treatment of social phobia with alprazolam. , 1988, The American journal of psychiatry.

[22]  M. Liebowitz,et al.  Placebo-controlled trial of moclobemide in social phobia , 1998, British Journal of Psychiatry.

[23]  M. Hamilton The assessment of anxiety states by rating. , 1959, The British journal of medical psychology.

[24]  Deborah C. Beidel,et al.  An empirically derived inventory to measure social fears and anxiety: The Social Phobia and Anxiety Inventory. , 1989 .

[25]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[26]  R. Heimberg,et al.  Validation of the Social Interaction Anxiety Scale and the Social Phobia Scale across the anxiety disorders. , 1997 .

[27]  A. Bellack,et al.  Concurrent validity of the Social Phobia and Anxiety Inventory , 1991 .

[28]  J. Gorman,et al.  Social phobia. Review of a neglected anxiety disorder. , 1985, Archives of general psychiatry.

[29]  L. Cronbach Essentials of psychological testing , 1960 .

[30]  R. Friend,et al.  Measurement of social-evaluative anxiety. , 1969, Journal of consulting and clinical psychology.